Attached files

file filename
8-K - 8-K - LANNETT CO INCa15-21025_18k.htm
EX-99.2 - EX-99.2 - LANNETT CO INCa15-21025_1ex99d2.htm
EX-99.1 - EX-99.1 - LANNETT CO INCa15-21025_1ex99d1.htm

Exhibit 99.3

 

Lannett

 

(dollars in thousands)

 

Lannett
Historical
Twelve
months

 

Lannett
Historical
Twelve
months

 

Lannett
Historical
Twelve
months

 

Lannett
Historical
Twelve
months

 

Last Twelve
Months Generic
Market Share per
IMS

 

Last Twelve Months
Generic Market
Position per IMS

 

 

 

 

 

 

Products

 

6/30/2012

 

6/30/2013

 

6/30/2014

 

6/30/2015

 

8/31/2015

 

8/31/2015

 

 

 

 

 

 

Levothyroxine

 

$

50,849

 

$

57,978

 

$

102,248

 

$

153,460

 

26

%

2

 

 

 

 

 

 

Ursodiol

 

5,991

 

6,114

 

6,578

 

65,262

 

19

%

3

 

 

 

 

 

 

Digoxin

 

10,895

 

11,669

 

54,721

 

48,959

 

40

%

1

 

 

 

 

 

 

Cocaine Topical

 

10,018

 

14,594

 

21,615

 

22,704

 

100

%

N/A

 

 

 

 

 

 

Acetazolamide

 

4,252

 

6,410

 

11,987

 

21,145

 

44

%

2

 

 

 

 

 

 

Other Products

 

40,985

 

54,290

 

76,621

 

95,307

 

 

 

 

 

 

 

 

 

 

Total net sales

 

$

122,990

 

$

151,054

 

$

273,771

 

$

406,837

 

 

 

 

 

 

 

 

 

 

 

KUPI

 

(dollars in thousands)

 

KUPI
Historical
Twelve
months

 

KUPI
Historical
Twelve
months

 

KUPI
Historical
Twelve
months

 

KUPI
Historical Six
months

 

KUPI Historical Six
months

 

KUPI Historical Last
Twelve Months

 

Last Twelve Months
Generic Market Share
per IMS

 

Last Twelve Months
Generic Market
Position per IMS

 

Products

 

12/31/2012

 

12/31/2013

 

12/31/2014

 

6/30/2014

 

6/30/2015

 

6/30/2015

 

8/31/2015

 

8/31/2015

 

Methylphenidate ER

 

 

59,251

 

151,034

 

83,319

 

36,539

 

104,254

 

17

%

3

 

Omeprazole

 

99,157

 

71,612

 

60,905

 

30,130

 

28,367

 

59,143

 

20

%

2

 

Oxybutynin

 

39,594

 

39,180

 

37,361

 

19,087

 

19,203

 

37,477

 

43

%

2

 

Tussionex

 

36,932

 

38,820

 

31,396

 

18,544

 

11,184

 

24,036

 

51

%

1

 

Nifedipine

 

27,041

 

22,782

 

20,919

 

10,161

 

8,096

 

18,853

 

16

%

2

 

Metadate

 

10,275

 

25,823

 

19,463

 

11,399

 

12,067

 

20,131

 

53

%

1

 

Pantoprazole

 

11,043

 

12,744

 

19,547

 

8,729

 

11,429

 

22,247

 

13

%

3

 

Other Products

 

48,730

 

60,234

 

70,472

 

32,933

 

36,484

 

74,024

 

 

 

 

 

Total net sales

 

$

272,772

 

$

330,446

 

$

411,097

 

$

214,301

 

$

163,369

 

$

360,165

 

 

 

 

 

Net sales to related party

 

9,609

 

10,714

 

18,841

 

10,983

 

12,316

 

20,174

 

 

 

 

 

Contract manufacturing revenue

 

37,698

 

35,673

 

33,082

 

16,589

 

15,849

 

32,342

 

 

 

 

 

Total net revenues

 

$

320,079

 

$

376,833

 

$

463,020

 

$

241,873

 

$

191,534

 

$

412,681